Contrast Enhanced Ultrasound Medical Imaging for Identifying Breast Masses
This clinical trial investigates the role of contrast enhanced ultrasound (CEUS) in identifying cystic breast masses as benign or malignant. Ultrasound is a diagnostic imaging test that uses sound waves to make pictures of the body without using radiation (x-rays). Ultrasounds are widely used to diagnose many diseases in the body. This trial may help researchers learn if using CEUS will help in determining whether or not an ultrasound guided biopsy is necessary.
Conditions studied
Breast Carcinoma
About this study
This clinical trial investigates the role of contrast enhanced ultrasound (CEUS) in identifying cystic breast masses as benign or malignant. Ultrasound is a diagnostic imaging test that uses sound waves to make pictures of the body without using radiation (x-rays). Ultrasounds are widely used to diagnose many diseases in the body. This trial may help researchers learn if using CEUS will help in determining whether or not an ultrasound guided biopsy is necessary.
Interventions
- Procedure: Contrast-Enhanced Ultrasound — Undergo CEUS
- Drug: Perflutren Lipid Microspheres — Given IV
- Drug: Sulfur Hexafluoride Lipid Microspheres — Given IV
Primary outcomes
- Radiomics-based ML-classifier framework (Up to 12 months)
- Performance of radiomics-based ML approach to prevent unnecessary biopsies (Up to 12 months)
Eligibility information
Study locations
- Los Angeles County-USC Medical Center, Los Angeles, California 90033 United States
- USC / Norris Comprehensive Cancer Center, Los Angeles, California 90033 United States
Source: ClinicalTrials.gov. Record last refreshed by Varda Clinical: 2026-09-27.